Skip to main content

Advertisement

Log in

Impact of preoperative symptom duration in patients undergoing lateral lumbar interbody fusion

  • Original Article - Spine - Other
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Few studies have examined the influence of preoperative symptom duration on clinical outcomes in patients undergoing lateral lumbar interbody fusion (LLIF) for degenerative conditions.

Methods

Patients undergoing LLIF presenting with radiculopathy and/or neurogenic claudication were separated into two groups: preoperative symptom duration < 1-year (shorter duration) versus duration ≥ 1-year (longer duration). Patients undergoing surgery for trauma/malignancy/infection were excluded. Patient-reported outcome measures (PROMs) of Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF), 12-Item Short Form Physical/Mental Component Score (SF-12 PCS/MCS), Patient Health Questionnaire-9 (PHQ-9), visual analog scale (VAS) back/leg, and Oswestry Disability Index (ODI) were collected at preoperative and postoperative time points.

Results

Eighty-two total patients, with 34 shorter-duration patients, were identified after propensity score matching for demographics. Longer-duration patients had higher estimated blood loss. All patients reported significant improvement in physical function, mental function, pain, and disability in at least one postoperative time point, except for SF-12 MCS in the shorter duration cohort. The longer duration cohort had higher MCID achievement in 12-week VAS back.

Conclusion

Patients undergoing LLIF demonstrated significant postoperative improvement in physical function, mental function, pain, and disability outcomes independent of preoperative symptom duration. Both cohorts, when compared by preoperative symptom duration, demonstrated similar postoperative PROM scores. Patients with longer preoperative symptom duration had higher 12-week leg pain MCID achievement. These findings suggest that delayed time to surgery may not lead to inferior clinical outcomes in patients undergoing LLIF for degenerative conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The data that support the findings of this study were generated at Rush University Medical Center and are available upon reasonable request from the corresponding author KS.

Abbreviations

ASA:

American Society of Anesthesiologists

BMI:

Body mass index

CCI:

Charlson comorbidity index

EBL:

Estimated blood loss

HNP:

Herniated nucleus pulposus

LLIF:

Lateral lumbar interbody fusion

MCID:

Minimum clinically important difference

MIS-TLIF:

Minimally invasive transforaminal lumbar interbody fusion

PHQ-9:

Patient Health Questionnaire-9

PROMs:

Patient-reported outcome measures

POD:

Postoperative day

ODI:

Oswestry Disability Index

OME:

Oral morphine equivalents

PROMIS-PF:

Patient-reported outcome measurement information system-physical function

SF-12 MCS:

12-Item Short Form Mental Component Score

SF-12 PCS:

12-Item Short Form Physical Component Score

SPORT:

Spine Patient Outcomes Research Trial

VAS:

Visual analog scale

References

  1. Alentado VJ, Lubelski D, Steinmetz MP, Benzel EC, Mroz TE (2014) Optimal duration of conservative management prior to surgery for cervical and lumbar radiculopathy: a literature review. Global Spine J 4(4):279–286

    Article  Google Scholar 

  2. Alluri R, Mok JK, Vaishnav A et al (2021) Intraoperative neuromonitoring during lateral lumbar interbody fusion. Neurospine 18(3):430–436

    Article  Google Scholar 

  3. Basques BA, Haws BE, Khechen B et al (2019) The effect of preoperative symptom duration on postoperative outcomes after a tubular lumbar microdiscectomy. Clin Spine Surg 32(1):E27–E30

    Article  Google Scholar 

  4. Cushnie D, Thomas K, Jacobs WB et al (2019) Effect of preoperative symptom duration on outcome in lumbar spinal stenosis: a Canadian Spine Outcomes and Research Network registry study. Spine J 19(9):1470–1477

    Article  Google Scholar 

  5. De la Garza-Ramos R, Ramhmdani S, Kosztowski T et al (2017) Prognostic value of preoperative Nurick grade and time with symptoms in patients with cervical myelopathy and gait impairment. World Neurosurg 105:314–320

    Article  Google Scholar 

  6. Ebersold MJ, Pare MC, Quast LM (1995) Surgical treatment for cervical spondylitic myelopathy. J Neurosurg 82(5):745–751

    Article  CAS  Google Scholar 

  7. Hamawandi SA, Sulaiman II, Abdulhameed AM (2022) Effect of duration of symptoms on the clinical and functional outcomes of lumbar microdiscectomy: a randomized controlled trial. Orthop Surg 14(1):157–168

    Article  Google Scholar 

  8. Hung M, Saltzman CL, Kendall R et al (2018) What are the MCIDs for PROMIS, NDI, and ODI instruments among patients with spinal conditions? Clin Orthop Relat Res 476(10):2027–2036

    Article  Google Scholar 

  9. Joseph JR, Smith BW, La Marca F, Park P (2015) Comparison of complication rates of minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion: a systematic review of the literature. Neurosurg Focus 39(4):E4

    Article  Google Scholar 

  10. Kim CH, Easley K, Lee JS et al (2020) Comparison of minimally invasive versus open transforaminal interbody lumbar fusion. Global Spine J 10(2 Suppl):143S-150S

    Article  Google Scholar 

  11. Lynch CP, Cha EDK, Jenkins NW et al (2021) The minimum clinically important difference for patient health questionnaire-9 in minimally invasive transforaminal interbody fusion. Spine 46(9):603–609

    Article  Google Scholar 

  12. Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ (2015) Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP. LLIF and ALIF J Spine Surg 1(1):2–18

    Google Scholar 

  13. Nie JW, Hartman TJ, MacGregor KR, Oyetayo OO, Zheng E, Singh K. (2022) Does preoperative symptom duration impact clinical outcomes after minimally invasive transforaminal lumbar interbody fusion in the ambulatory setting? World Neurosurg. Published online. https://doi.org/10.1016/j.wneu.2022.07.055

  14. Omidi-Kashani F, GhayemHasankhani E, Kachooei AR, Rahimi MD, Khanzadeh R (2014) Does duration of preoperative sciatica impact surgical outcomes in patients with lumbar disc herniation? Neurol Res Int 2014:565189

    Article  Google Scholar 

  15. Parker SL, Adogwa O, Paul AR et al (2011) Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine 14(5):598–604

    Article  Google Scholar 

  16. Radcliff KE, Rihn J, Hilibrand A et al (2011) Does the duration of symptoms in patients with spinal stenosis and degenerative spondylolisthesis affect outcomes?: analysis of the Spine Outcomes Research Trial. Spine 36(25):2197–2210

    Article  Google Scholar 

  17. Salzmann SN, Shue J, Hughes AP (2017) Lateral lumbar interbody fusion-outcomes and complications. Curr Rev Musculoskelet Med 10(4):539–546

    Article  Google Scholar 

  18. Tarazona D, Boody B, Hilibrand AS et al (2019) Longer preoperative duration of symptoms negatively affects health-related quality of life after surgery for cervical radiculopathy. Spine 44(10):685–690

    Article  Google Scholar 

  19. Tetreault L, Wilson JR, Kotter MRN et al (2019) Is preoperative duration of symptoms a significant predictor of functional outcomes in patients undergoing surgery for the treatment of degenerative cervical myelopathy? Neurosurgery 85(5):642–647

    Article  Google Scholar 

  20. Yoo JS, Patel DS, Hrynewycz NM, Brundage TS, Mogilevsky FA, Singh K (2020) The effect of preoperative symptom duration on postoperative outcomes after minimally invasive transforaminal lumbar interbody fusion. Clin Spine Surg 33(6):E263–E268

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

James W. Nie, BS: conceptualization, methodology, visualization, formal analysis, software, investigation, writing—original draft, writing—review and editing. Timothy J. Hartman, MD: conceptualization, methodology, visualization, formal analysis, software, investigation, writing—original draft, writing—review and editing. Omolabake O. Oyetayo, BS: project administration, data curation, investigation, writing—review and editing. Keith R. MacGregor, BS: project administration, data curation, investigation, writing—review and editing. Eileen Zheng, BS: project administration, data curation, investigation, writing—review and editing. Alexander W. Parsons, BS: project administration, data curation, investigation, writing—review and editing. Arash J. Sayari, MD: conceptualization, methodology, supervision, resources, investigation, writing—review and editing. Dustin H. Massel, MD: conceptualization, methodology, supervision, resources, investigation, writing—review and editing. Kern Singh, MD: conceptualization, methodology, supervision, resources, investigation, writing—review and editing.

Corresponding author

Correspondence to Kern Singh.

Ethics declarations

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board (IRB) of Rush University Medical Center (ORA #14051301).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Competing interests

Kern Singh, MD receives royalties from Zimmer Biomet, Stryker, RTI Surgical, Lippincott Williams and Wilkins, Thieme, Jaypee Publishing, and Slack Publishing. Kern Singh, MD owns stock in Avaz Surgical LLC and Vital 5 LLC. Kern Singh, MD holds a consulting position with Zimmer Biomet and K2M. Kern Singh, MD holds board membership with Vital 5 LLC. Kern Singh, MD is on the editorial board of Contemporary Spine Surgery. Kern Singh, MD received a research grant from the Cervical Spine Research Society.

Kern Singh, MD holds board membership with TDi LLC and Minimally Invasive Spine Study Group and receives no compensation as board member. Kern Singh, MD is on the editorial board of Orthopedics Today and Vertebral Columns and receives no compensation as member of the editorial board. Kern Singh, MD is on the board of directors of Cervical Spine Research Society, International Society for the Advancements of Spine Surgery, and American Academy of Orthopaedic Surgeons and receives no compensation as member of the board of directors.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Spine

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nie, J.W., Hartman, T.J., Oyetayo, O.O. et al. Impact of preoperative symptom duration in patients undergoing lateral lumbar interbody fusion. Acta Neurochir 165, 89–97 (2023). https://doi.org/10.1007/s00701-022-05436-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-022-05436-y

Keywords

Navigation